作者：
Caroline L,Minkus [1]
;
Maxwell,Pistilli [2]
;
Kurt A,Dreger [3]
;
Tonetta D,Fitzgerald [2]
;
Abhishek R,Payal [4]
;
Hosne,Begum [5]
;
R Oktay,Kaçmaz [6]
;
Douglas A,Jabs [7]
;
Robert B,Nussenblatt [8]
;
James T,Rosenbaum [9]
;
Grace A,Levy-Clarke [10]
;
H Nida,Sen [8]
;
Eric B,Suhler [11]
;
Jennifer E,Thorne [7]
;
Nirali P,Bhatt [2]
;
C Stephen,Foster [12]
;
Jeanine M,Buchanich [13]
;
John H,Kempen [14]
;
Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study Research Group
作者单位：
From the Department of Ophthalmology and Visual Neurosciences, University of Minnesota, Minneapolis, Minnesota; Department of Ophthalmology, Northwestern University Feinberg School of Medicine, Chicago, Illinois; Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts; Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts.
[1]
Department of Ophthalmology, the Perelman School of Medicine, the University of Pennsylvania, Philadelphia, Pennsylvania.
[2]
Department of Population, Family, and Reproductive Health, the Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland; Department of Ophthalmology, the Johns Hopkins School of Medicine, Baltimore, Maryland.
[3]
Department of Ophthalmology, the Johns Hopkins School of Medicine, Baltimore, Maryland; Massachusetts Eye Research and Surgery Institute, Waltham, Massachusetts.
[4]
Department of Ophthalmology, the Johns Hopkins School of Medicine, Baltimore, Maryland.
[5]
Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts; Massachusetts Eye Research and Surgery Institute, Waltham, Massachusetts; Mallinckrodt Pharmaceuticals, Staines-upon-Thames, United Kingdom.
[6]
Department of Ophthalmology, the Johns Hopkins School of Medicine, Baltimore, Maryland; Department of Epidemiology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
[7]
Laboratory of Immunology, National Eye Institute, National Institutes of Health, Bethesda, Maryland.
[8]
Department of Epidemiology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland; Department of Ophthalmology, Oregon Health and Science University, Portland, Oregon; Department of Medicine, Oregon Health and Science University, Portland, Oregon; Legacy Devers Eye Institute, Portland, Oregon.
[9]
Laboratory of Immunology, National Eye Institute, National Institutes of Health, Bethesda, Maryland; The Tampa Bay Uveitis Center, St. Petersburg, Florida.
[10]
Department of Ophthalmology, Oregon Health and Science University, Portland, Oregon; Portland Veteran's Affairs Medical Center, Portland, Oregon.
[11]
Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts;; Massachusetts Eye Research and Surgery Institute, Waltham, Massachusetts.
[12]
Department of Biostatistics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
[13]
Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts; Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts;; Department of Ophthalmology, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia; MCM Eye Unit, MyungSung Christian Medical Center (MCM General Hospital) and MyungSung Medical School, Addis Ababa, Ethiopia. Electronic address: John_kempen@meei.harvard.edu.
[14]
DOI
10.1016/j.ajo.2021.02.032
PMID
33713679
发布时间
2022-09-02
换一批
换一批
